Header Logo

Connection

Julie Schmittdiel to Antihypertensive Agents

This is a "connection" page, showing publications Julie Schmittdiel has written about Antihypertensive Agents.
Connection Strength

2.043
  1. Health care system-level factors associated with performance on Medicare STAR adherence metrics in a large, integrated delivery system. Med Care. 2015 Apr; 53(4):332-7.
    View in: PubMed
    Score: 0.457
  2. Initial persistence with antihypertensive therapies is associated with depression treatment persistence, but not depression. J Clin Hypertens (Greenwich). 2014 Jun; 16(6):412-7.
    View in: PubMed
    Score: 0.427
  3. Health system factors and antihypertensive adherence in a racially and ethnically diverse cohort of new users. JAMA Intern Med. 2013 Jan 14; 173(1):54-61.
    View in: PubMed
    Score: 0.392
  4. Characteristics of diabetic patients associated with achieving and maintaining blood pressure targets in the Adherence and Intensification of Medications program. Chronic Illn. 2014 Mar; 10(1):60-73.
    View in: PubMed
    Score: 0.102
  5. The association between medication adherence and treatment intensification with blood pressure control in resistant hypertension. Hypertension. 2012 Aug; 60(2):303-9.
    View in: PubMed
    Score: 0.094
  6. A comparison between antihypertensive medication adherence and treatment intensification as potential clinical performance measures. Circ Cardiovasc Qual Outcomes. 2012 May; 5(3):276-82.
    View in: PubMed
    Score: 0.093
  7. Age-dependent gender differences in hypertension management. J Hypertens. 2011 May; 29(5):1005-11.
    View in: PubMed
    Score: 0.087
  8. Study protocol: the Adherence and Intensification of Medications (AIM) study--a cluster randomized controlled effectiveness study. Trials. 2010 Oct 12; 11:95.
    View in: PubMed
    Score: 0.084
  9. The association of patient-physician gender concordance with cardiovascular disease risk factor control and treatment in diabetes. J Womens Health (Larchmt). 2009 Dec; 18(12):2065-70.
    View in: PubMed
    Score: 0.079
  10. When more is not better: treatment intensification among hypertensive patients with poor medication adherence. Circulation. 2008 Jun 03; 117(22):2884-92.
    View in: PubMed
    Score: 0.071
  11. Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med. 2008 May; 23(5):588-94.
    View in: PubMed
    Score: 0.070
  12. Detection and recognition of hypertension in anxious and depressed patients. J Hypertens. 2012 Dec; 30(12):2293-8.
    View in: PubMed
    Score: 0.024
  13. Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high-performing health systems: the adherence and intensification of medications cluster randomized, controlled pragmatic trial. Circulation. 2012 Jun 12; 125(23):2863-72.
    View in: PubMed
    Score: 0.023
  14. Adherence to cardiovascular disease medications: does patient-provider race/ethnicity and language concordance matter? J Gen Intern Med. 2010 Nov; 25(11):1172-7.
    View in: PubMed
    Score: 0.021
  15. Treatment intensification and risk factor control: toward more clinically relevant quality measures. Med Care. 2009 Apr; 47(4):395-402.
    View in: PubMed
    Score: 0.019

© 2024 Kaiser Permanente